Cardlytics, Inc. (CDLX)
NASDAQ: CDLX · Real-Time Price · USD
0.6700
+0.0050 (0.75%)
May 14, 2026, 10:52 AM EDT - Market open

Cardlytics Statistics

Total Valuation

Cardlytics has a market cap or net worth of $36.90 million. The enterprise value is $186.85 million.

Market Cap36.90M
Enterprise Value 186.85M

Important Dates

The last earnings date was Thursday, May 7, 2026, after market close.

Earnings Date May 7, 2026
Ex-Dividend Date n/a

Share Statistics

Cardlytics has 55.07 million shares outstanding. The number of shares has increased by 6.65% in one year.

Current Share Class 55.07M
Shares Outstanding 55.07M
Shares Change (YoY) +6.65%
Shares Change (QoQ) +1.06%
Owned by Insiders (%) 3.98%
Owned by Institutions (%) 27.51%
Float 47.68M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.17
Forward PS 0.22
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio 3.68
P/OCF Ratio 3.54
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.88
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 18.75

Financial Position

The company has a current ratio of 2.17

Current Ratio 2.17
Quick Ratio 2.12
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF 21.08
Interest Coverage -3.44

Financial Efficiency

Return on equity (ROE) is -356.04% and return on invested capital (ROIC) is -9.93%.

Return on Equity (ROE) -356.04%
Return on Assets (ROA) -7.70%
Return on Invested Capital (ROIC) -9.93%
Return on Capital Employed (ROCE) -19.07%
Weighted Average Cost of Capital (WACC) 4.82%
Revenue Per Employee $767,844
Profits Per Employee -$344,313
Employee Count275
Asset Turnover 0.67
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -68.77% in the last 52 weeks. The beta is 0.69, so Cardlytics's price volatility has been lower than the market average.

Beta (5Y) 0.69
52-Week Price Change -68.77%
50-Day Moving Average 0.88
200-Day Moving Average 1.26
Relative Strength Index (RSI) 30.82
Average Volume (20 Days) 935,614

Short Selling Information

The latest short interest is 8.78 million, so 15.95% of the outstanding shares have been sold short.

Short Interest 8.78M
Short Previous Month 9.06M
Short % of Shares Out 15.95%
Short % of Float 18.42%
Short Ratio (days to cover) 6.19

Income Statement

In the last 12 months, Cardlytics had revenue of $211.16 million and -$94.69 million in losses. Loss per share was -$1.76.

Revenue211.16M
Gross Profit 100.21M
Operating Income -39.01M
Pretax Income -106.97M
Net Income -94.69M
EBITDA -15.64M
EBIT -39.01M
Loss Per Share -$1.76
Full Income Statement

Balance Sheet

The company has $59.80 million in cash and $210.03 million in debt, with a net cash position of -$150.23 million or -$2.73 per share.

Cash & Cash Equivalents 59.80M
Total Debt 210.03M
Net Cash -150.23M
Net Cash Per Share -$2.73
Equity (Book Value) -4.00M
Book Value Per Share -0.07
Working Capital 69.17M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $10.35 million and capital expenditures -$389,000, giving a free cash flow of $9.97 million.

Operating Cash Flow 10.35M
Capital Expenditures -389,000
Depreciation & Amortization 23.37M
Net Borrowing -11.00M
Free Cash Flow 9.97M
FCF Per Share $0.18
Full Cash Flow Statement

Margins

Gross margin is 47.46%, with operating and profit margins of -18.47% and -44.84%.

Gross Margin 47.46%
Operating Margin -18.47%
Pretax Margin -50.66%
Profit Margin -44.84%
EBITDA Margin -7.41%
EBIT Margin -18.47%
FCF Margin 4.72%

Dividends & Yields

Cardlytics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.65%
Shareholder Yield -6.65%
Earnings Yield -258.55%
FCF Yield 27.21%

Analyst Forecast

The average price target for Cardlytics is $2.00, which is 198.51% higher than the current price. The consensus rating is "Hold".

Price Target $2.00
Price Target Difference 198.51%
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 5